Am J Transl Res. 2026 Oct 15;18(10):9030-9047. doi: 10.62347/YJBM1193. eCollection 2026.
ABSTRACT
OBJECTIVE: This study aimed to elucidate the mechanisms underlying the protective effects of Wenpi Decoction (WPD) against chronic kidney disease (CKD) progression using animal experimental approaches.
METHODS: The active components of WPD and their relevant therapeutic targets for CKD were identified based on the Traditional Chinese Medicine Systems Pharmacology (TCMSP) platform. A protein-protein interaction (PPI) network was constructed using the STRING database. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed in R to identify key biological processes and signaling pathways. The associations among NLRP3 (NOD-like receptor protein 3), CKD, inflammatory pathways, and immune cell infiltration were further evaluated using network-based analyses, and the causal relationship between NLRP3 and CKD was investigated through Mendelian randomization analysis. The effects of WPD were then validated in a cisplatin-induced CKD mouse model.
RESULTS: Network pharmacology analysis identified 751 potential target proteins and indicated that inflammation-related signaling pathways may represent major mechanisms underlying the effects of WPD. NLRP3 was highly expressed in CKD patients and showed potential diagnostic value. Further analyses suggested that NLRP3 was involved in inflammatory pathways and immune cell infiltration. Mendelian randomization confirmed a causal relationship between NLRP3 and CKD. Animal experiments demonstrated that WPD improved renal function, attenuated renal fibrosis, and downregulated the renal expression levels of NLRP3, IL-6, TNF-α, and caspase-1.
CONCLUSION: Inflammation-related pathways, particularly the NLRP3/caspase-1 signaling axis, may play a critical role in the therapeutic effects of WPD in the cisplatin-induced CKD model. WPD effectively alleviated renal dysfunction and fibrosis, potentially via suppressing activation of the NLRP3/caspase-1 signaling pathway.
PMID:43067954 | PMC:PMC13788473 | DOI:10.62347/YJBM1193